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Background: Whey protein increases postprandial serum insulin levels. This has been associated with increased
serum levels of leucine, isoleucine, valine, lysine, threonine and the incretin hormone glucose-dependent
insulinotropic polypeptide (GIP). We have examined the effects of these putative mediators of whey’s action on
insulin secretion from isolated mouse Langerhans islets.
Methods: Mouse pancreatic islets were incubated with serum drawn from healthy individuals after ingestion of
carbohydrate equivalent meals of whey protein (whey serum), or white wheat bread (control serum). In addition
the effect of individual amino acid combinations on insulin secretion was also tested. Furthermore, the stimulatory
effects of whey serum on insulin secretion was tested in vitro in the absence and presence of a GIP receptor
antagonist ((Pro(3))GIP[mPEG]).
Results: Postprandial amino acids, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1
(GLP-1) responses were higher after whey compared to white wheat bread. A stimulatory effect on insulin release
from isolated islets was observed with serum after whey obtained at 15 min (+87%, P < 0.05) and 30 min (+139%,
P < 0.05) postprandially, compared with control serum. The combination of isoleucine, leucine, valine, lysine and
threonine exerted strong stimulatory effect on insulin secretion (+270%, P < 0.05), which was further augmented
by GIP (+558% compared to that produced by glucose, P < 0.05). The stimulatory action of whey on insulin
secretion was reduced by the GIP-receptor antagonist (Pro(3))GIP[mPEG]) at both 15 and 30 min (−56% and −59%,
P < 0.05).
Conclusions: Compared with white wheat bread meal, whey causes an increase of postprandial insulin, plasma
amino acids, GIP and GLP-1 responses. The in vitro data suggest that whey protein exerts its insulinogenic effect by
preferential elevation of the plasma concentrations of certain amino acids, GIP and GLP-1.
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Dairy products produce higher insulin responses (Insulin
index, II, 90–98) than expected from their comparatively
low glycemic indices (GI 15–30) [1,2]. Insulinogenic
effects from dairy products have been observed in
healthy subjects, both when ingested as a single meal* Correspondence: ulrika.gunnerud@appliednutrition.lth.se
2Department of Applied Nutrition and Food Chemistry, Lund University,
Lund, Sweden
5Applied Nutrition and Food Chemistry, Lund University, P.O. Box 124, 221 00
Lund, Sweden
Full list of author information is available at the end of the article
© 2012 Salehi et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or[1], and when included into a mixed meal [2,3]. The
insulin-releasing capacity of dairy products has been
attributed to the protein fraction, and both whey and ca-
sein have been shown to stimulate insulin secretion in
healthy subjects [4,5]. Particularly the whey fraction and
release of amino acids during digestion has been pro-
posed to underlie the insulinogenic properties of milk
[6]. Indeed, several amino acids are known to stimulate
insulin secretion both in vivo and in vitro [7-13]. Previ-
ous work has shown that postprandial plasma concen-
trations of isoleucine, leucine, valine, lysine and threoninetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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acids have been implicated as mediators of the insulino-
genic effect [6]. In addition, the incretin hormone GIP has
been shown to be present at higher postprandial levels
after ingestion of whey compared to white wheat bread
(WWB) [4,6,14], and may thus contribute to the insulino-
tropic effect.
The objective of this study was to investigate the
mechanisms underlying the insulinogenic effect of whey
protein. We aimed to determine whether or not serum
responses of amino acids (isoleucine, leucine, valine, ly-
sine and threonine) and GIP, following whey ingestion
exerted their effects on insulin stimulation directly on
the pancreatic β-cells. We have compared the effects of
postprandial serum withdrawn from healthy individuals
after ingestion of equi-carbohydrate portions of whey or
white wheat bread (WWB), respectively, on insulin se-
cretion in vitro. The impact of isoleucine, leucine, valine,
lysine and threonine, as well as of a mixture thereof was
studied using an in vitro model with isolated islets from
mice [6]. In the light of our previous studies showing
significant increases in serum GIP following oral admin-
istration of whey, in vitro insulin release in response to
selected amino acids was tested with or without addition
of a GIP antagonist [6].
Materials and methods
Human meal studies
Serum for in vitro analysis of insulin secretion of
Langerhans islets
Six (4 M, 2 W), non-smoking healthy volunteers, aged
20–30 y, with normal fasting blood glucose and body
mass indices and without any history of previous drug
treatment participated in the study. Two meals, whey
protein and white wheat bread (WWB), matched with
regard to carbohydrate content (25 g) were provided in
the morning after an overnight fast. Lactose was the
carbohydrate source in the whey meal, and starch in the
WWB meal. The protein amount was 3.7 g in the WWB
meal and 16.7 g in the whey meal. The participants were
instructed to avoid alcohol, excessive physical activity
and food rich in dietary fibers on the day before the test
and to eat a standardized meal consisting of white wheat
bread between 9 and 10 pm and then nothing except
small amounts of water. When reporting at the labora-
tory in the morning, a peripheral catheter was inserted
into an antecubital vein and fasting blood was sampled
(time 0). Thereafter, the test meal was served and com-
pleted within 12 min. Coffee or tea (150 ml) was served
15 min after start, and each subject maintained the same
drink throughout the study. Blood samples were then
taken 7.5, 15, 30 and 45 min after the start of the meal.
Sera obtained after whey ingestion (“whey serum”) and
WWB (“control serum”) were stored at -20°C untilanalyzed. Blood samples were also taken at 0, 15, 30 and
45 min for analysis of free amino acids, GIP and GLP-1
in plasma. All test subjects gave their informed consent
and were aware of the possibility of withdrawing
from the study at any time. The study was approved by
Ethics Committee of the Faculty of Medicine at Lund
University.
Serum for in vitro analysis of insulin secretion of
Langerhans islets with or without GIP receptor antagonist
((Pro(3))GIP[mPEG])
The meal study was performed in the same way as men-
tioned above, with the difference that it was 12 healthy
test subjects (7 W, 5 M). One test drink and one refer-
ence drink were included in the study, which were
served as breakfast on two different occasions. The test
drinks consisted of 18 g of whey protein. The reference
drink was glucose in 250 g water. Blood samples were
taken at 0, 15 and 30 min.
Blood analysis
Free amino acids were purified by mixing 200 μl 10%
sulfosalicylic acid with 800 μl plasma to precipitate high
molecular-weight proteins. The amino acids were then
analyzed with an amino acid analyzer (LC 5001; Biotro-
nik, München, Germany) by ion-exchange chromatog-
raphy. The amino acids were separated by using
standard lithium citrate buffers of pH 2.85, 2.89, 3.20,
4.02 and 3.49. The post column derivatization was per-
formed with ninhydrin [15].
Plasma glucose-dependent insulinotropic polypeptide
(GIP) and glucagon-like peptide 1 (GLP-1) concentrations
were measured after extraction of plasma with 70% etha-
nol. For the GIP radioimmunoassay [16], antiserum R65
(directed against the C-terminus) was used. Human GIP
and 125I-labelled human GIP (70 Bq/nmol) were used for
standards and tracer. The plasma concentrations of GLP-
1 were measured as previously reported [17] using anti-
bodies directed against the amidated C-terminus of GLP-1
(code no. 89390) against standards of synthetic GLP-1 7–
36 amide. For both assays, sensitivity was < 1 pmol/l, the
intra-assay CV was < 6% at 20 pmol/l, and the recovery
of standard (which was added to plasma before extraction)
was  100% when corrected for losses inherent in the
plasma extraction procedure.
In vitro analysis of Langerhans islets
Animals
Female mice of the NMRI strain (B&K Universal, Sollen-
tuna, Sweden), weighing 25–30 g, were used for all
experiments. The mice were fed a standard pellet diet
(B&K Universal, Sollentuna, Sweden) and tap water ad
libitum. The mice were killed by cervical dislocation fol-
lowed by decapitation (with ethical approval).
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Collagenase (CLS 4) was obtained from Sigma Chemicals
Corp. (St. Louis, MO., USA). Bovine serum albumin was
from ICN Biomedicals (High Wycombe, England). GIP-
antagonist ((Pro(3))GIP[mPEG]) was kindly provided by
Professor PR Flatt, (University of Ulster, Coleraine, UK).
All other chemicals were from Merck AG (Darmstadt,
Germany). The radioimmunoassay kits for insulin and
glucagon were from Diagnostika (Falkenberg, Sweden)
and Eurodiagnostika (Malmö, Sweden), respectively.
Experimental protocol
All islet experiments were performed with mouse pancre-
atic islets isolated by retrograde injection of a collagenase
solution via the bile-pancreatic duct [18-20]. The islets
were collected under a stereomicroscope at room
temperature, and transferred to incubation vials (12 islets
per 1.0 ml incubation buffer in each vial). They were then
pre-incubated for 30 min at 37°C in 1 ml of Krebs-Ringer
bicarbonate (KRB) buffer, pH 7.4, supplemented with 10
mmol/l HEPES and 0.1% bovine serum albumin and 1
mmol/l glucose as previously described [18]. Each batch
of islets was then gassed with 95% O2 and 5% CO2 to ob-
tain constant pH and oxygenation. After pre-incubation,
the buffer was changed to an identical medium in the
presence or absence of different test agents (human
serum, amino acids and/or GIP) and 8.3 mmol/l glucose.
The KRB buffer was compensated for the glucose levels in
the serum (measured separately) when the serum was
added to the buffer to a final concentration of 8.3 mmol/l.
Islets were thereafter incubated for 60 min at 37°C in a
shaking incubator (30 cycles per min). Immediately after
incubation, aliquots of the medium were removed for
radioimmunoassay of insulin [21]. All experiments were
performed in at least four replicates.
Serum from 6 healthy subjects was pooled yielding
one sample for each time point and product (see human
meal study above). Thereafter, the glucose, insulin, GIP
and GLP-1 concentrations, as well as amino acid levels
were analyzed in postprandial whey and control serum.
The insulin concentrations present originally in the
serum were subtracted from the concentrations obtained
after the incubation with isolated islets in order to de-
termine the amount of insulin secreted during the
incubation.
Previous work has established that the plasma concen-
trations of isoleucine, leucine, valine, lysine and threo-
nine are elevated following a whey meal [4]. The impact
of each of these amino acids at a standard concentration
of 4 mM on insulin secretion from isolated islets was
therefore examined. In addition, the effects of a cocktail
consisting of 4 mM of each amino acid with and without
100 nM GIP were tested. These are standard concentra-
tions used for in vitro work [22,23]. Furthermore, thestimulatory effects of whey serum (obtained at 0, 15 and
30 min after meal ingestion) on insulin secretion was
tested in vitro in the absence and presence of a 100 nM
GIP receptor antagonist ((Pro(3))GIP[mPEG]) using
pooled serum from 12 healthy subjects (see human meal
study, above).
Statistical methods
The results are expressed as means ± SEM for the indi-
cated number of observations. Probability levels of ran-
dom differences were determined by analysis of variance
followed by Tukey-Kramer’s multiple comparisons test
using GraphPad PrismTM, (version 4.03; GraphPad Soft-
ware Inc, San Diego, CA), when comparing the differ-
ences in insulin releasing capacities of whey and control
serum, and to evaluate the effect of the GIP antagonist.
Significant differences in insulin release among different
amino acids were assessed by ANOVA followed by
Tukey’s multiple comparisons test (MINITAB, release
14.13; Minitab Inc, State Collage, PA). Differences result-
ing in P < 0.05 were considered statistically significant.
Results
Post-prandial plasma response of amino acids, GIP and
GLP-1
The mean plasma concentration of valine, isoleucine,
leucine, threonine and lysine determined 0, 15, 30 and
45 min after ingestion of whey and WWB, respectively,
are presented in Figure 1. At 45 min, the concentrations
were 2.2-, 2.8-, 1.5-, 1.2- and 1.9-fold higher after inges-
tion of whey than WWB for leucine, isoleucine, valine,
threonine and lysine, respectively. The plasma levels of
both GIP and GLP-1 were ~2-fold higher at 30 and
45 min after ingestion of whey compared with WWB
(Figure 2).
Effects of post-prandial serum on in vitro insulin secretion
We examined the effects of whey (grey bars) or control
(white bars) serum samples obtained at 0, 7.5, 15, 30 and
45 min after ingestion of the meal on insulin secretion
from freshly isolated mouse islets exposed to 8.3 mM
glucose (Figure 3). Whereas control serum was without
effect on insulin secretion, whey serum obtained at 15
and 30 min after meal ingestion stimulated insulin secre-
tion >2.5-fold.
Effects of amino acids on in vitro insulin secretion
We tested the effects of the five amino acids that are
increased in response to whey (leucine, isoleucine, val-
ine, threonine and lysine; cf. Figure 1). When tested at a
concentration of 4 mM, only leucine (+105%, P < 0.05)
evoked a statistically significant stimulation of insulin se-
cretion relative that produced by glucose alone (Figure 4).
A cocktail consisting of all five amino acids (each
Figure 1 Amino acid responses in humans. Mean (± SEM) values of isoleucine, leucine, valine, lysine and threonine in plasma obtained at
different time points in response to the whey (▲) and WWB (■) meal.
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release beyond (+270%, P < 0.05) that obtained with
glucose alone or any of the amino acids when they were
tested individually. The effect of the cocktail was
enhanced ~2-fold (P < 0.05) by GIP.Figure 2 Incretin responses in humans. Mean (± SEM) values of GIP (A)
to the whey (▲) and WWB (■) meal.Effects of a GIP antagonist on insulin secretion
The stimulatory action of whey serum on insulin secre-
tion, with or without added GIP-receptor antagonist, is
seen in Figure 5. The insulin secretion, exceeding that
produced by glucose alone, was significantly reduced inand GLP-1 (B) in plasma obtained at different time points in response
Figure 3 Insulin secretion of Langerhans islets incubated with
human serum. Insulin secretion of isolated pancreatic islets
incubated with serum obtained from healthy subjects after ingestion
of whey (grey bars) and WWB (control, white bars), and 8.3 mM
glucose alone (reference, black bar). The islets were pooled from 8
different NMRI mice and values are means ± SEM for 10
observations in each group performed at three different occasions.
Significant differences between whey and control serum for each
time point are denoted by **P< 0.01, ***P< 0.001.
Figure 4 Insulin secretion of Langerhans islets incubated with
amino acid. Insulin secretion from isolated pancreatic islets
incubated at 8.3 mM glucose in the absence or presence of leucine,
isoleucine, valine, lysine and threonine, a cocktail of the 5 amino
acids or a cocktail + GIP. Values are means ± SEM for 8 observation
in each group performed at three different occasions. The
experiments were performed on the islets isolated and pooled from
6 different NMRI mice. Values with different letters are significantly
different, P< 0.05.
Figure 5 Insulin secretion of Langerhans islet incubated with
human serum in presence of a GIP-receptor antagonist. Insulin
secretion from isolated mice pancreatic islets incubated at
8.3 mmol/l glucose +whey serum (obtained before intake time 0 as
well as at 15 and 30 min after meal ingestion) in the absence (white
bars) and presence (black bars) of GIP-receptor antagonist ((Pro(3))
GIP[mPEG]) (100 nmol/l). Values are means ± SEM for 8 observations
in each group performed at three different occasions on the isolated
islets from 6 different NMRI mice. Significant differences between
absence and presence of the antagonist are denoted by * P< 0.05;
* * P< 0.005.
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l) with −56% at 15 min (P < 0.05) and −59% at 30 min
(P < 0.01).
Discussion
In this study whey ingestion resulted in a 1.2- to 2.8-
fold increase in plasma concentration of leucine, isoleu-
cine, valine, threonine and lysine relative the basal
plasma levels and those obtained after ingestion of
white wheat bread. It has previously been described that
specific mixtures of amino acids do stimulate insulin se-
cretion [6,10]. Thus, it is conceivable that the observed
stimulation of insulin secretion is due to an increased
level of the specific amino acids in vivo. The amino acid
cocktail was shown to be superior to the single amino
acids, with respect to in vitro insulin secretion, in sup-
port of such an opinion. Additionally, adding GIP to the
amino acid cocktail further enhanced insulin stimula-
tory effect on the β-cells, indicating an involvement also
of this incretin.
GIP as well as GLP-1 is a strong insulinotropic agent
[24], and it has recently been reported that the two
incretins have different effects on the insulin secretion,
with GIP appearing to be more effective at normogly-
cemic levels and GLP-1 during hyperglycemia [25]. In
previous studies we have demonstrated that whey pro-
tein affects GIP rather than GLP-1 [4,6,14]. Other stud-
ies have reported stimulation of GLP-1 as well [26] and
in the present study whey protein clearly stimulated
both GIP and GLP-1. Stimulation also of GLP-1 provides
an alternative explanation for the insulinogenic action ofwhey. In the present study it was evident that whey in-
gestion increased the plasma concentration of incretins
more than white wheat bread in healthy humans.
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the in vitro insulinotropic action of whey serum signifi-
cantly, and future work should address the mechanism
by which whey enhances release of GIP from the enteric
K-cells.
Insulin secretion in response to amino acids is inter-
esting in terms of treatment of type-2 diabetes. Most of
the insulinogenic amino acids trigger insulin secretion
by mechanisms that differ from those utilized by glucose
[27]. In type-2 diabetes, the insulinogenic effects of
amino acids may remain unaffected even after long-term
diabetes [12,14,28]. Interestingly, addition of essential
amino acids to a diet in poorly regulated elderly patients
with type 2 diabetes improved metabolic control and
lowered fasting blood glucose and serum insulin levels,
as well as lowered levels of glycated hemoglobin
(HbA1c) [29,30]. Possibly, the improved metabolic con-
trol results from increased muscle mass and improved
insulin sensitivity, in addition to the insulinotropic effect
of the amino acid supplementation.
A recent study identified the whey fraction, rather
than the casein fraction, as the major insulin secreta-
gogue in milk [4]. The different insulin-stimulating cap-
acity of the whey and casein fractions may be secondary
to differences in the rate of gastric emptying and diges-
tion, with whey proteins being classified as rapidly
released proteins [31,32]. It should be noted, however,
that “whey serum” (i.e. obtained from subjects that had
ingested whey protein) exerts a direct stimulatory effect
on insulin secretion from isolated mouse islets. We
therefore conclude that whey increases the plasma con-
centration of metabolites with insulinotropic capacity
that act directly on the β-cells. In this context it is note-
worthy that the stimulatory effect of the whey serum
was strongest at 15 and 30 min after ingestion and that
no stimulation was seen at 45 min.
The stimulation of insulin release by the whey serum
in vitro was not caused by any changes in glucose
resulting from the addition of the serum samples, as
this was adjusted for. Although several metabolic and
hormonal parameters could be differentially modified
in the serum from whey-ingested subjects, the observa-
tion that GIP was elevated may be of particular signifi-
cance. Indeed, inclusion of the GIP-antagonist ((Pro(3))
GIP[mPEG]) in the incubation media markedly sup-
pressed the stimulatory effects of the serum from
whey-ingested subjects on insulin secretion from iso-
lated islets. However, it should be emphasized that the
results of present investigation illustrate an in vitro ob-
servation which needs to be verified in an appropriate
in vivo animal model. Moreover, it will be interesting
to confirm these observations using human islets to
further study the differences or similarities in this
context.In conclusion, our work on isolated mouse pancreatic
islets suggests that the insulinogenic capacity of whey
proteins is mediated by postprandial elevation of specific
plasma amino acids, and GIP. In addition, plasma GLP-1
levels were elevated and this may exert an additional
stimulatory effect and the relative influence of the med-
iators of insulin secretion remains to be established.
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